GlassScriptPhysician profile
Emily Campito
NPI 1891012977
$709.13
in general payments reported to CMS, 2019-2025
16 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $48.06 · 2022: $95.07 · 2023: $131 · 2024: $122 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $165.03 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $83.48 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $75.36 | 2024-2025 | |
| Pfizer INC. | $65.55 | 2019-2025 | |
| Biogen, INC. | $49.94 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $41.68 | 2022 | |
| Mayne Pharma Commercial LLC | $37.60 | 2022-2023 | |
| Exeltis, USA INC. | $31.93 | 2024 | Slynd |
| Lupin INC. | $29.24 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.78 | 2019-2020 | |
| Medicem INC. | $25.11 | 2023 | |
| Therapeuticsmd, INC. | $19.93 | 2022 | |
| Millicent US INC | $16.74 | 2025 | Femlyv |
| Coopersurgical, INC. | $14.91 | 2019 | |
| Avion Pharmaceuticals | $13.54 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Campito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.